Teladoc Inc (NYSE:TDOC) CEO Jason N. Gorevic sold 40,000 shares of the stock in a transaction that occurred on Monday, March 12th. The shares were sold at an average price of $43.27, for a total transaction of $1,730,800.00. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.

Teladoc Inc (NYSE:TDOC) traded up $0.15 during trading hours on Wednesday, hitting $42.95. 1,029,467 shares of the stock were exchanged, compared to its average volume of 1,120,000. The firm has a market capitalization of $2,600.00 and a price-to-earnings ratio of -20.65. Teladoc Inc has a 1 year low of $20.85 and a 1 year high of $44.65. The company has a debt-to-equity ratio of 0.37, a current ratio of 3.87 and a quick ratio of 3.87.

How to Become a New Pot Stock Millionaire

TDOC has been the topic of a number of recent analyst reports. Canaccord Genuity upped their price target on shares of Teladoc from $43.00 to $45.00 and gave the company a “buy” rating in a research note on Wednesday, February 28th. Chardan Capital restated a “buy” rating and set a $47.00 price target (down previously from $48.00) on shares of Teladoc in a research note on Wednesday, February 28th. Deutsche Bank upped their price target on shares of Teladoc to $45.00 and gave the company a “buy” rating in a research note on Friday, March 2nd. Cantor Fitzgerald restated a “hold” rating and set a $35.00 price target (up previously from $31.00) on shares of Teladoc in a research note on Tuesday, February 27th. Finally, ValuEngine upgraded shares of Teladoc from a “sell” rating to a “hold” rating in a research note on Friday, February 2nd. One analyst has rated the stock with a sell rating, five have given a hold rating and twelve have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average price target of $40.71.

Several large investors have recently added to or reduced their stakes in TDOC. Carillon Tower Advisers Inc. acquired a new stake in shares of Teladoc in the fourth quarter worth $57,973,000. Bamco Inc. NY increased its stake in shares of Teladoc by 751.9% in the third quarter. Bamco Inc. NY now owns 1,455,900 shares of the health services provider’s stock worth $48,263,000 after acquiring an additional 1,285,000 shares during the period. Jennison Associates LLC increased its stake in shares of Teladoc by 130.0% in the third quarter. Jennison Associates LLC now owns 1,793,338 shares of the health services provider’s stock worth $59,449,000 after acquiring an additional 1,013,707 shares during the period. Gilder Gagnon Howe & Co. LLC increased its stake in shares of Teladoc by 753.9% in the third quarter. Gilder Gagnon Howe & Co. LLC now owns 1,138,577 shares of the health services provider’s stock worth $37,744,000 after acquiring an additional 1,005,239 shares during the period. Finally, Champlain Investment Partners LLC acquired a new stake in shares of Teladoc in the fourth quarter worth $29,290,000.

COPYRIGHT VIOLATION NOTICE: “Teladoc Inc (TDOC) CEO Jason N. Gorevic Sells 40,000 Shares” was originally reported by Daily Political and is the property of of Daily Political. If you are accessing this piece on another website, it was illegally copied and republished in violation of international copyright & trademark laws. The original version of this piece can be accessed at https://www.dailypolitical.com/2018/03/14/teladoc-inc-tdoc-ceo-jason-n-gorevic-sells-40000-shares.html.

About Teladoc

Teladoc, Inc is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.

Insider Buying and Selling by Quarter for Teladoc (NYSE:TDOC)

Receive News & Ratings for Teladoc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc and related companies with MarketBeat.com's FREE daily email newsletter.